Syndecans and the Lymphoid System

References

• Kim C. W., Goldberger O. A., Gallo R. L., Bemfield M. Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Molecular Biology of the Cell 1994; 5: 797–805
   PubMed Web of Science ®Google Scholar
• Woods A., Couchman J. R. Syndecans: synergestic activators of cell adhesion. Trends in Cell Biology 1998; 8: 189–192
   PubMed Web of Science ®Google Scholar
• Zimmermann P., David G. The syndecans, tuners of transmembrane signaling. FASEB Journal 1999; 13: S91–S100
   PubMed Web of Science ®Google Scholar
• Carey D. J. Syndecans: multifunctional cell-surface co-receptors. Biochemical Journal 1997; 327: 1–16
   PubMed Web of Science ®Google Scholar
• Oh E. S., Couchman J. R., Woods A. Serine phosphorylation of ssyndecan-2 proteoglycan cytoplasmyc domain. Archives of Biochemistry and Biophysics 1997; 344: 67–74
   PubMed Web of Science ®Google Scholar
• Spring J., Goldberger O. A., Jenkins N. A., Gilbert D. J., Copeland N. G., Bernfield M. Mapping of the syndecan genes in the mouse: linkage with members of the myc gene family. Genomics 1994; 21: 597–601
   PubMed Web of Science ®Google Scholar
• Kaukonen J., Alanen-Kurki L., Jalkanen M., Palotie A. The mapping and visual ordering of the human syndecan-1 and N-myc genes near the telomeric region of chromosome 2p. Human Genetics 1997; 99: 295–7
   PubMed Web of Science ®Google Scholar
• Mali M., Jaakola P., Arvilommi A. M., Jalkanen M. Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans. Journal of Biological Chemistry 1990; 265: 6884–6889
   PubMed Web of Science ®Google Scholar
• Vihinen T., Auvinen P., Alanen-Kurki L., Jalkanen M. Structural organization and genomic sequence of mouse syndecan-1 gene. Journal of Biological Chemistry 1993; 268: 7261–7269
   PubMedGoogle Scholar
• Oettinger H. F., Streeter H., Lose E., Copeland N. G., Gilbert D. J., Justice M. J., Jenkins N. A., Mohandas T., Bern-Field M. Chromosome mapping of the murine syndecan gene. Genomics 1991; 11: 334–338
   PubMed Web of Science ®Google Scholar
• Vihinen T., Maata A., Jaakola P., Auvinen P., Jalkanen M. Functional characterization of mouse syndecan-1 promoter. Journal of Biological Chemistry 1996; 271: 2532–15541
   Google Scholar
• Hinkes M. T., Goldberger O. A., Neumann P. E., Kokenyesi R., Bernfield M. Organization and promoter activity of the mouse syndecan-1 gene. Journal of Biological Chemistry 1993; 268: 11440–11448
   PubMed Web of Science ®Google Scholar
• Cizmeci-Smith G., Langen E., Youkey J., Showalter L. J., Carey D. J. Arteriosclerosis, Thrombosis, and Vascular Biology 1997; 17: 172–180
   PubMed Web of Science ®Google Scholar
• Elenius K., Maatta A., Salmivirta M., Jalkanen M. Growth factors induce 3T3 cells to express bFGF-binding syndecan. Journal of Biological Chemistry 1992; 267: 6435–6441
   PubMed Web of Science ®Google Scholar
• Bemfield M., Kokenyesi R., Kato M., Hinkes M. T., Spring J., Gallo R. L., Lose E. J. Biology of the syndecans: a family of four transmembrane heparan sulfate proteoglycans. Annual Review of Cell Biology 1992; 8: 365–393
   PubMedGoogle Scholar
• Kökényesi R., Bernfield M. Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1. Journal of Biological Chemistry 1994; 269: 12304–12309
   PubMed Web of Science ®Google Scholar
• Habuchi H., Habuchi O., Kimata K. Biosynthesis of heparan sulfate and heparin. How are the multifunctional glycosaminoglycans built up. Trends in Glycoscience and Glycotechnology 1998; 10: 65–80
   Web of Science ®Google Scholar
• Lyon M., Gallagher J. T. Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion. Matrix Biology 1998; 17: 485–493
   PubMed Web of Science ®Google Scholar
• Kiefer M. C., Ichihara M., Swiedler S. J., Crawford K., Stephans J. C., Barr P. J. The molecular biology of heparan sulfate fibroblast growth factor receptor. Annuals of the New York Academy of Sciences 1991; 638: 167–76
   PubMed Web of Science ®Google Scholar
• Bemfield M., Kokenyesi R., Kato M, Hinkes M. T., Spring J., Gallo R. L., Lose E. J. Biology of the syndecans: a family of four transmembrane heparan sulfate proteoglycans. Annual Review of Cell Biology 1992; 8: 365–393
   PubMedGoogle Scholar
• Elenius K., Jalkanen M. Function of the syndecans -a family of cell surface proteoglycans. Journal of Cell Science 1994; 107: 2975–82
   PubMed Web of Science ®Google Scholar
• Van Putten J. P., Paul S. M. Binding of syndecan-like cell surface proteoglycan receptors is required for Neisseria gonorhoae entry into human mucosal cells. EMBO Journal 1995; 14: 2144–54
   PubMed Web of Science ®Google Scholar
• Fervert U., Sinnis P., Cerami C., Scheffler W., Takacs B., Nussenzweig V. Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated the surface membrane of hepatocytes. Journal of Experimental Medicine 1993; 177: 1287–98
   PubMed Web of Science ®Google Scholar
• Dhodapkar M. V., Abe E., Theus A., Lacy M., Langford J. K., Barlogie B., Sanderson R. D. Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth and bone cell differentiation. Blood 1998; 91: 2679–2688
   PubMed Web of Science ®Google Scholar
• Lander A. D. Proteoglycans: Master regulators of molecular encounter. Matrix Biology 1998; 17: 465–472
   PubMed Web of Science ®Google Scholar
• Steinfield R., VanDen Berghe H., David G. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. Journal of Cell Biology 1996; 133: 319–323
   Google Scholar
• Engeelmann S., Ebeling O., Schwartz-Albiez R. Modulated glycolysation of proteoglycans during differentiation of human B lymphocytes. Biochemica Biophysica Acta 1995; 1267: 6–14
   PubMed Web of Science ®Google Scholar
• Submarian S. V., Fitzgerald M. L., Bemfield M. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. Journal of Biological Chemistry 1997; 272: 14713–14720
   PubMed Web of Science ®Google Scholar
• Ihreke N. S., Piatt J. L. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell surface molecules. Journal of Cellular Physiology 1996; 168: 625–637
   PubMed Web of Science ®Google Scholar
• Reiland J., Ott V. L., Lebakken C. S., Yeaman C., McCarthy J., Rapraeger A. C. Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1. Biochemical Journal 1996; 319: 39–47
   PubMed Web of Science ®Google Scholar
• Wijdenes J., Clement C., Klein B., Dore J. M. CD 138 cluster report. Leukocyte typing VI, Kishimoto. Garland, New York 1997
   Google Scholar
• Bernfield M., Kökényesi R., Kato M., Hinkes M. T., Spring J., Gallo R. L., Lose E. J. Biology of the syndecans: a family of four transmembrane heparan sulfate proteoglycans. Annual Review of Cell Biology 1992; 8: 365–393
   PubMedGoogle Scholar
• Mali M., Andtfolk H., Miettinen H. M., Jalkanen M. Suppression of tumor cell growth by syndecan-1 ectodomain. Journal of Biological Chemistry 1994; 269: 27795–27798
   PubMed Web of Science ®Google Scholar
• Carey D. J., Bendt K. M., Stahl R. C. The cytoplasmic domain of syndecan-1 is required for cytoskeleton association but not detergent insolubility. Identification of essential cytoplasmic domain residues. Journal of Biological Chemistry 1996; 271: 15253–15260
   PubMed Web of Science ®Google Scholar
• Lebakken C. S., Rapraeger A. C. Syndecan-1 mediated cell spreading in transfected human lymphoblastoid (Raji) cells. Journal of the Cell Biology 1996; 132: 1209–1221
   PubMed Web of Science ®Google Scholar
• Carey D. J., Stahl R. C., Tucker B., Bendt K. A., Cizmeci-Smith G. Aggregation-induced association of syndecan-1 with microfilaments mediated by cytoplasmic domain. Experimental Cell Research 1994; 214: 12–21
   PubMed Web of Science ®Google Scholar
• Carey D. J., Bendt K. M., Stahl R. C. The cytoplasmic domain of syndecan-1 is required for cytoskeleton association but not detergent insolubility. Journal of Biological Chemistry 1996; 271: 15253–15260
   PubMed Web of Science ®Google Scholar
• Mochly-Rosen D., Gordon A. S. Anchoring proteins for protein kinase C: means for isozyme selectivity. FASEB Journal 1998; 12: 35–42
   PubMed Web of Science ®Google Scholar
• Oh E. S., Couchman J. R., Woods A. Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. Journal of Biological Chemistry 1997; 272: 8133–8136
   PubMed Web of Science ®Google Scholar
• Oh E. S., Couchman J. R., Woods A. Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C. Journal of Biological Chemistry 1997; 212: 11805–11811
   Web of Science ®Google Scholar
• Oh E. S., Woods A., Lim S. T., Theibert A. W., Couchman J. R. Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4,5-biphosphate. Journal of Biological Chemistry 1998; 273: 10624–10629
   PubMed Web of Science ®Google Scholar
• Lee D., Oh E. S., Woods A., Couchman J. R., Lee W. Solution structure of a syndecan-4 cytoplasmic domain and its interaction with phosphatidylinositol 4,5-biphosphate. J. Biol. Chem. 1998; 273: 13022–13029
   PubMed Web of Science ®Google Scholar
• Baciu P C, Goetinck P R. Protein kinase C regulates the recruitment of syndecan-4 into focal contact. Molecular Biology of Cell 1995; 6: 1503–1513
   PubMed Web of Science ®Google Scholar
• Kinnunen T., Kaksonen M., Saarinen J., Kalkkinen N., Peng H. B., Rauvala H. Cortactin/Src-kinase signaling pathway is involved in N-syndecan-dependent neurite out-growth. Journal of Biological Chemistry 1998; 273: 10702–10708
   PubMed Web of Science ®Google Scholar
• Fanning A. S., Anderson J. M. PDZ domains and the formation of protein networks at the plasma membrane. Current Topics of Microbiology 1998; 228: 209–233
   PubMed Web of Science ®Google Scholar
• Grootjans J. J., Zimmerman P., Reekmans G., Smets A., Degeest G., Diirr J., David G. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proceedings of National Academy of Sciences USA 1997; 94: 13683–13688
   PubMed Web of Science ®Google Scholar
• Bredt D. S. Sorting out genes that regulate epithelial and neuronal polarity. Cell 1998; 94: 691–694
   PubMed Web of Science ®Google Scholar
• Fuki I. V., Kuhn K. M., Lomazov I. R., Rothman V. L., Tuszynski G. P., Iozzo R. V., Swenson T. L., Fisher E. A., Williams K. J. The syndecan family of proteoglycans. Journal of Clinical Investigation 1997; 100: 1611–1622
   PubMed Web of Science ®Google Scholar
• Sanderson R. D., Lalor P., Bemfield M. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regulation 1989; 1: 27–35
   PubMedGoogle Scholar
• Carbone A., Gloghini A., Gaidano G., Franceschi S., Capello D., Drexler H. G., Falini B., Dalla-Favera R. Expression status of BCL-6 and Syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease. Blood 1998; 92: 2220–2228
   PubMed Web of Science ®Google Scholar
• Wrenshall L. E., Cerra F. B., Rubinstein P., Piatt J. L. Regulation by heparan sulfate and interleukin alpha of ontogenic expression of T cell receptor, CD4, and CD8 in developing thymus. Human Immunology 1993; 38: 165–171
   PubMed Web of Science ®Google Scholar
• Yamashita Y., Oritani K., Miyoshi E. K., Wall R., Bern-Field M., Kincade P. W. Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes. Journal of Immunology 1999; 162: 5940–5948
   PubMed Web of Science ®Google Scholar
• Stocker G., Drezinek Z., Just U., Ostertag W., Siebertz B., Grelling H., Haubeck H. D. Proteoglycan synthesis in human and murine haematopoietic progenitor cell lines: isolation and characterisation of a heparan sulafte proteoglycan as major proteoglycan from the human haematopoietic cell line TF-1. Biochemical Journal 1996; 317: 203–212
   PubMed Web of Science ®Google Scholar
• Oritani K., Kincade P. W. Identification of stromal cell products that interact with pre-B cells. Journal of Cellular Biology 1996; 134: 771–782
   PubMed Web of Science ®Google Scholar
• Sneed T. B., Stanley D. J., Young L. A., Sanderson R. D. Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells. Cellular Immunology 1994; 153: 456–467
   PubMed Web of Science ®Google Scholar
• Rapraeger A. Transforming growth factor (type beta) promotes the addition of chondroitin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia. Journal of Cellular Biology 1989; 109: 2509–2518
   PubMed Web of Science ®Google Scholar
• Messika E. J., Lu P. S., Sung Y. J., Yao T., Chi J. T., Chien Y. H., Davis M. M. Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development. Journal of Experimental Medicine 1998; 188: 515–525
   PubMed Web of Science ®Google Scholar
• Turner C. A., Mack D. H., Davis M. M. B-limp, a novel Zinc finger containing protein that can drive the maturation of B lymphocytes into imunglobulin-secreting cells. Ceim 1994; 297–306
   Google Scholar
• Usui T., Wakatsuki Y., Matsunaga Y., Kaneko S., Kosek H., Kita T. Overexpression of B cell specific activator protein (BSAP/Pax-5) in late cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype. Journal of Immunology 1997; 158: 3097–3204
   Google Scholar
• Stanley M. J., Liebersbach B. F., Liu W., Anhalt D. J., Sanderson R. D. Heparan sulfate mediated cell aggregation. Syndecan-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells. Journal of Biological Chemistry 1995; 270: 5077–5083
   PubMed Web of Science ®Google Scholar
• Liebersbach B. F., Sanderson R. D. Expression of syndecan-1 inhibits cell invasion into type I collagen. Journal of Biological Chemistry 1994; 269: 20013–20019
   PubMed Web of Science ®Google Scholar
• Liu W., Litwack E. D., Stanley M. J., Langford J. K., Lander A. D., Sanderson R. D. Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions. Journal of Biological Chemistry 1998; 273: 22825–22832
   PubMed Web of Science ®Google Scholar
• Olwin B. B., Rapraeger A. Repression of myogenic differentiation by aFGF, bFGF and K-FGF is dependent on cellular heparan sulfate. Journal of Cellular Biology 1992; WS: 631–639
   Web of Science ®Google Scholar
• Mitsiadis T. A., Salmivirta M., Muramatsu T., Muramatsu H., Rauvala H., Lehtonen E., Jalkanen M., Thesleff I. Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleitropin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development 1995; 121: 37–51
   PubMed Web of Science ®Google Scholar
• Filla M. S., Dam P., Rapraeger A. C. The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity. Journal of Cellular Physiology 1998; 174: 310–321
   PubMed Web of Science ®Google Scholar
• Kopper L., Sebestyen A., Gallai M., Kovalszky I. Syndecan-1 - a new piece in B-cell puzzle. Pathology Oncology Research 1997; 3: 183–191
   PubMedGoogle Scholar
• Inki P., Stenback F., Talve L., Jalkanen M. Immunhistochemical localization of syndecan in mouse skin tumours induced by UV irradiation. Loss of expression associated with malignant transformation. American Journal of Pathology 1991; 139: 1333–1340
   PubMed Web of Science ®Google Scholar
• Levy P., Munier A., Baron-Delage S., Di Gioia Y., Gespach C., Capeau J., Cherqui G. Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes. British Journal of Cancer 1996; 74: 423–431
   PubMed Web of Science ®Google Scholar
• Dhodapkar M. V., Sanderson R. D. Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: a multifunctional regulator of cell behavior within the tumor micro-environment. Leukemia Lymphoma 1999; 34: 35–43
   PubMed Web of Science ®Google Scholar
• Carbone A., Gaidano G., Gloghini A., Larocca L. M., Capello D., Canzonieri V., Antinori A., Tirelli U., Falini B., Dalla-Favera R. Differential expression of BCL-6, CD138/Syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndroma-related non-Hodgkin's lymphomas. Blood 1998; 91: 747–755
   PubMed Web of Science ®Google Scholar
• Carbone A., Gloghini A., Gattei V, Degan M., Improta S., Aldinucci D., Canzonieri V., Perin T., Volpe R., Gaidano G., Zagonel V., Pinto A. Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1. Blood 1997; 89: 3787–3794
   PubMed Web of Science ®Google Scholar
• Sebestyén A., Kovalszky I., Mihalik R., Gallai M., Bocsi J., Laszlo E., Benedek S Z., Sreter L, Kopper L. Expression of syndecan-1 in human B cell chronic lymphocytic leukaemia. European Journal of Cancer 1997; 33: 2273–2277
   PubMed Web of Science ®Google Scholar
• Gaidano G., Gloghini A., Gattei V., Rossi M. F., Cilia A. M., Godeas C., Degan M., Perin T., Canzonieri V., Aldinucci D., Saglio G., Carbone A., Pinto A. Association of Kaposi's Sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/Syndecan-1 antigen. Blood 1997; 90: 4894–4900
   PubMed Web of Science ®Google Scholar
• Larocca L. M., Capello D., Rinelli A., Nori S., Antinori A., Gloghini A., Cingolani A., Migliazza A., Saglio G., Camilleri-Broet S., Raphael M., Carbone A., Gaidano G. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B-cells. Blood 1998; 92: 1011–1019
   PubMed Web of Science ®Google Scholar
• Gattei V., Godeas C., Degan M., Rossi F. M., Aldinucci D., Pinto A. Characterization of anti-CD138 monoclonal antibodies as tools for investigating the molecular polymorphism of syndecan-1 in human lymphoma cells. British Journal of Haematology 1999; 104: 152–162
   PubMed Web of Science ®Google Scholar
• Bonnefoix T., Sotto M.-R., Gressin R., Martin I., Garban F., Leroux D., Renversez J.-C., Sotto J.-J. Phenotypic, morphologic changes and Ig secretion induced on B-NHL cells in vitro by interferon alpha and all-trans-retinoic acid: possible progression toward a more differentiated state. European Journal of Haematology 1998; 61: 84–92
   PubMed Web of Science ®Google Scholar
• Carbone A., Gloghini A., Larocca L. M., Antinori A., Falini B., Tirelli U., Della-Favera R., Gaidano G. Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells. Blood 1999; 93: 2319–2326
   PubMed Web of Science ®Google Scholar
• Carbone A., Gaidano G., Gloghini A., Pastore C., Saglio G., Tirelli U., Dalla-Favera R., Falini B. BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas. Inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression. American Journal of Pathology 1997; 150: 155–165
   PubMed Web of Science ®Google Scholar
• Jourdan M, Ferlin M., Legouffe E., Horvathova E., Liautard J., Rossi J. F., Wijdenes J., Brochier J., Klein B. The myeloma cell antigen syndecan-1 is lost by apop-totic myeloma cells. Brinish Journal of Haematology 1998; 100: 637–646
   PubMed Web of Science ®Google Scholar
• Wijdenes J., Vooijs W. C., Clement C., Post J., Morard F., Vita N., Laurent P., Sun R. X., Klein B., Dore J. M. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. British Journal of Haematology 1996; 94: 318–323
   PubMed Web of Science ®Google Scholar
• Ridley R. C., Xiao H., Hata H., Woodliff J., Epstein J., Sanderson R. D. Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood 1993; 81: 767–774
   PubMed Web of Science ®Google Scholar
• Dhodapkar M. V., Kelly T., Theus A., Athota A. B., Barlogie B., Sanderson R. D. Elevated levels of shed syndecan-1 correlate with tumor mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma. British Journal of Haematology 1997; 99: 368–371
   PubMed Web of Science ®Google Scholar
• Kaushal G. P., Xiong X., Athota A. B., Rozypal T. L., Sanderson R. D., Kelly T. Syndecan-1 expression suppresses the level of myeloma matrix metalloproteinase-9. British Journal of Haematology 1999; 104: 365–373
   PubMed Web of Science ®Google Scholar
• Rawstron A. C., Owen R. G., Davies F. E., Johnson R. J., Jones R. A., Richards S. J., Evans P. A., Child A., Smith G. M., Jack A. S. Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. British Journal of Haematology 1997; 97: 46–55
   PubMed Web of Science ®Google Scholar
• Sanderson R. D., Turnbull J. E., Gallagher J. T., Lander A. D. Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior. Journal of Biological Chemistry 1994; 269: 13100–13106
   PubMed Web of Science ®Google Scholar
• Rawstron A., Barrens S., Blythe D., Davies F, English A., Pratt G., Child A., Morgan G., Jack A. Distribution of myeloma plasma cells in peripheral blood and bone marrow correlated with CD56 expression. British Journal of Haematology 1999; 104: 138–143
   PubMed Web of Science ®Google Scholar
• Witzig T. E., Kimlinger T., Stenson M., Themeau T. Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia. Leukemia Lymphoma 1998; 31: 167–175
   PubMed Web of Science ®Google Scholar
• Gattei V., Godeas C., Degan M., Rossi F. M., Aldinucci D. Characterization of anti-CD138 monoclonal antibodies as tools for investigating the molecular polymorphism of syndecan-1 in human lymphoma cells. British Journal Haematology 1999; 104: 152–162
   PubMed Web of Science ®Google Scholar